AzTrials
AzTrials

Parastomal HerniaGRECCAR 07NCT01380860

Primary Prevention of Peristomial Hernias Via Parietal Prostheses

A study testing Colostomy with mesh implantation and Simple colostomy in people with Parastomal Hernia, run by Centre Hospitalier Universitaire de Nīmes at 22 sites in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to compare rates of hernia formation between colostomies created with no hernia preventing mesh versus colostomies created with a particular mesh. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Parastomal Hernia
What is being tested?
Colostomy with mesh implantation and Simple colostomy
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
200 participants
Where
22 sitesFrance
Study dates
Nov 2012to 31 Dec 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • The patient has given informed consent
  • The patient must be affiliated with a health insurance programme
  • The patient must be available for 24 months of follow-up
  • The patient requires a colostomy (primo-event, ie first colostomies only)

Who cannot join

  • The patient is currently participating in another interventional study
  • The patient is in an exclusion period determined by a previous study
  • The patient is under guardianship
  • The patient refuses to sign the consent
  • It is impossible to communicate information to the patient (does not read French)
  • The patient is pregnant
Show all 11Show fewer
  • The patient is breastfeeding
  • There is a contra-indication for any treatment used in this study
  • The subject has already had a colostomy
  • The subject has peritonitis
  • The subject needs a colostomy for infectious reasons

Trial locations and contacts

22 sites in 1 country.

22 sites in 1 country

France22 sites
  • CHRU de Besancon

    Besançon, 25030

  • CHU de Bordeaux

    Bordeaux, 33075

  • CHRU de Clermont Ferrand

    Clermont-Ferrand, 63058

  • APHP - Hôpital Beaujon

    Clichy, 92110

  • Hôpital Albert Michallon, CHU de Grenoble

    Grenoble, 38043

  • APHP - Centre Hospitalier Universitaire de Bicêtre

    Le Kremlin-Bicêtre, 94275

  • Centre de Lutte Contre le Cancer - Centre Oscar Lambret

    Lille, 59020

  • CHRU de Lille - Hôpital Claude Huriez

    Lille, 59037

  • CHU de Lyon

    Lyon, 69317

  • Centre Régional de Lutte Contre le Cancer - Institut Paoli-Calmettes

    Marseille, 13009

  • APHM - Hôpital La Timone Adultes

    Marseille, 13385

  • Centre Régional de Lutte Contre le Cancer Val d'Aurelle - Paul Lamarque

    Montpellier, 34298

  • CHU de Nantes

    Nantes, 44093

  • Centre Hospitalier Universitaire de Nîmes

    Nîmes, 30029

  • APHP - Hôpital Lariboisière

    Paris, 75010

  • APHP - Hôpital Saint-Antoine

    Paris, 75571

  • APHP - Groupe Hospitalier Pitié-Salpetrière

    Paris, 75651

  • Hôpital Pontchailou

    Rennes, 35033

  • CHU de Rouen

    Rouen, 76038

  • Centre Régional de Lutte contre le Cancer Centre Paul Strauss

    Strasbourg, 67065

  • CHU de Toulouse

    Toulouse

  • CH de Vichy - Jacques Larin

    Vichy, 03207

Other trials in France

About this study

Official title: Primary Prevention of Peristomial Hernias Via Parietal Prostheses: a Randomized, Multicentric Study

The purpose of this study is to compare rates of hernia formation between colostomies created with no hernia preventing mesh versus colostomies created with a particular mesh.

Read the detailed description

Previous studies indicate that implanting mesh for peristomal hernia repair may efficiently prevent hernia relapse. However, mesh provides a good infection site, which is not a desirable characteristic for a material adjacent to a colostomy "port". Our goal is to implement a high-quality, randomized trial to demonstrate whether or not systematic mesh implantation upon primary hernia creation is an effective means of avoiding this common and troublesome complication.

Being tested
Colostomy with mesh implantation, Simple colostomy
Keywords
mesh, hernia
Medical subject headings
Hernia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Colostomy with mesh implantationProcedure or surgery

    Colostomy with mesh implantation

  • Simple colostomyProcedure or surgery

    Colostomy with no mesh implantation.

Study groups in NCT01380860
Study groupRoleWhat they receive
MeshExperimentalThe patients allocated to this arm of the study will have mesh (Covidien France: mono filament polyester bidimensional knit) implanted in association with their colostomy.
Receives: Procedure: Colostomy with mesh implantation
No meshActive comparatorThe patients allocated to this arm of the protocol will not receive mesh implantation with their colostomy.
Receives: Procedure: Simple colostomy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Presence/absence of a peristomal hernia

    The occurrence of peristomal hernias is determined in both groups every three months up until 24 months. The presence of absence of a hernia is detected by clinical exam, and at 24 months by an additional radiology exam. The primary outcome concerns rates at 24 months, primo-events only.

    Measured: 24 months

Secondary outcomes (135)
  1. Presence/absence of peristomal hernia

    The presence of absence of a hernia is detected by clinical exam.

    Measured: 12 months

  2. Days of hospitalisation

    The number of days spent in the hospital after the surgical intervention.

    Measured: 1 month

  3. Operating time (minutes)

    Measured: Day 1

  4. Estimation of blood loss during the operation (ml)

    Measured: Day 1

  5. Was stomal repair necessary for the patient? yes/no

    Measured: 24 months

  6. Was relocation of the colostomy required? yes/no

    Measured: 24 months

  7. Presence/absence of complications

    Complications include: retraction, stenosis, prolapse, disunion, necrosis, abcess, infections, occlusion, strangulation, perforation, eczema, dermatitis, erythema, ulceration

    Measured: 24 months

  8. Patient difficulty for fitting his/her colostomy with the appropriate sac.

    A visual analog scale is used to determine how difficult it is for a patient to fit his/her colostomy with an appropriate device. 0: perfect adhesion; 10: the device does not adjust to the shape of my skin, and I have permanent leakage.

    Measured: 24 months

  9. Pain around the colostomy

    A visual analog scale is used to assess the patient's perception of pain around the stomy site.

    Measured: 24 months

  10. Abdominal pain

    A visual analog scale is used to assess the patient's perception of abdominal pain.

    Measured: 24 months

  11. Pain medication consumption

    Measured: 24 months

  12. Number of colostomy leaks per day

    Measured: 24 months

  13. Number of colostomy sac changes per day

    Measured: 24 months

  14. Does the patient consider fitting a sac to his/her colostomy to be a difficult task? yes/no

    Measured: 24 months

  15. Questionnaire Stoma-QOL

    Validated assessment of quality of life.

    Measured: 24 months

  16. Exposition of the prothesis (mesh): yes/no

    Measured: 24 months

  17. Questionnaire Stoma-QOL

    Validated assessment of quality of life.

    Measured: 12 months

  18. Questionnaire Stoma-QOL

    Validated assessment of quality of life.

    Measured: 1 month

  19. Presence/absence of peri-operative complications

    Measured: Day 1

  20. Pain around the colostomy

    A visual analog scale is used to assess the patient's perception of pain around the stomy site.

    Measured: Day 1

  21. Pain around the colostomy

    A visual analog scale is used to assess the patient's perception of pain around the stomy site.

    Measured: 1 month

  22. Pain around the colostomy

    A visual analog scale is used to assess the patient's perception of pain around the stomy site.

    Measured: 3 months

  23. Pain around the colostomy

    A visual analog scale is used to assess the patient's perception of pain around the stomy site.

    Measured: 6 months

  24. Pain around the colostomy

    A visual analog scale is used to assess the patient's perception of pain around the stomy site.

    Measured: 9 months

  25. Pain around the colostomy

    A visual analog scale is used to assess the patient's perception of pain around the stomy site.

    Measured: 12 months

  26. Pain around the colostomy

    A visual analog scale is used to assess the patient's perception of pain around the stomy site.

    Measured: 15 months

  27. Pain around the colostomy

    A visual analog scale is used to assess the patient's perception of pain around the stomy site.

    Measured: 18 months

  28. Pain around the colostomy

    A visual analog scale is used to assess the patient's perception of pain around the stomy site.

    Measured: 21 months

  29. Abdominal pain

    A visual analog scale is used to assess the patient's perception of abdominal pain.

    Measured: Day 1

  30. Abdominal pain

    A visual analog scale is used to assess the patient's perception of abdominal pain.

    Measured: 1 month

  31. Abdominal pain

    A visual analog scale is used to assess the patient's perception of abdominal pain.

    Measured: 3 months

  32. Abdominal pain

    A visual analog scale is used to assess the patient's perception of abdominal pain.

    Measured: 6 months

  33. Abdominal pain

    A visual analog scale is used to assess the patient's perception of abdominal pain.

    Measured: 9 months

  34. Abdominal pain

    A visual analog scale is used to assess the patient's perception of abdominal pain.

    Measured: 12 months

  35. Abdominal pain

    A visual analog scale is used to assess the patient's perception of abdominal pain.

    Measured: 15 months

  36. Abdominal pain

    A visual analog scale is used to assess the patient's perception of abdominal pain.

    Measured: 18 months

  37. Abdominal pain

    A visual analog scale is used to assess the patient's perception of abdominal pain.

    Measured: 21 months

  38. Presence/absence of peristomal hernia

    The presence of absence of a hernia is detected by clinical exam.

    Measured: 1 month

  39. Presence/absence of peristomal hernia

    The presence of absence of a hernia is detected by clinical exam.

    Measured: 3 months

  40. Presence/absence of peristomal hernia

    The presence of absence of a hernia is detected by clinical exam.

    Measured: 6 months

  41. Presence/absence of peristomal hernia

    The presence of absence of a hernia is detected by clinical exam.

    Measured: 9 months

  42. Presence/absence of peristomal hernia

    The presence of absence of a hernia is detected by clinical exam.

    Measured: 15 months

  43. Presence/absence of peristomal hernia

    The presence of absence of a hernia is detected by clinical exam.

    Measured: 18 months

  44. Presence/absence of peristomal hernia

    The presence of absence of a hernia is detected by clinical exam.

    Measured: 21 months

  45. Presence/absence of complications

    Complications include: retraction, stenosis, prolapse, disunion, necrosis, abcess, infections, occlusion, strangulation, perforation, eczema, dermatitis, erythema, ulceration

    Measured: 1 month

  46. Presence/absence of complications

    Complications include: retraction, stenosis, prolapse, disunion, necrosis, abcess, infections, occlusion, strangulation, perforation, eczema, dermatitis, erythema, ulceration

    Measured: 3 months

  47. Presence/absence of complications

    Complications include: retraction, stenosis, prolapse, disunion, necrosis, abcess, infections, occlusion, strangulation, perforation, eczema, dermatitis, erythema, ulceration

    Measured: 6 months

  48. Presence/absence of complications

    Complications include: retraction, stenosis, prolapse, disunion, necrosis, abcess, infections, occlusion, strangulation, perforation, eczema, dermatitis, erythema, ulceration

    Measured: 9 months

  49. Presence/absence of complications

    Complications include: retraction, stenosis, prolapse, disunion, necrosis, abcess, infections, occlusion, strangulation, perforation, eczema, dermatitis, erythema, ulceration

    Measured: 12 months

  50. Presence/absence of complications

    Complications include: retraction, stenosis, prolapse, disunion, necrosis, abcess, infections, occlusion, strangulation, perforation, eczema, dermatitis, erythema, ulceration

    Measured: 15 months

  51. Presence/absence of complications

    Complications include: retraction, stenosis, prolapse, disunion, necrosis, abcess, infections, occlusion, strangulation, perforation, eczema, dermatitis, erythema, ulceration

    Measured: 18 months

  52. Presence/absence of complications

    Complications include: retraction, stenosis, prolapse, disunion, necrosis, abcess, infections, occlusion, strangulation, perforation, eczema, dermatitis, erythema, ulceration

    Measured: 21 months

  53. Patient difficulty for fitting his/her colostomy with the appropriate sac.

    A visual analog scale is used to determine how difficult it is for a patient to fit his/her colostomy with an appropriate device. 0: perfect adhesion; 10: the device does not adjust to the shape of my skin, and I have permanent leakage.

    Measured: Day 1

  54. Patient difficulty for fitting his/her colostomy with the appropriate sac.

    A visual analog scale is used to determine how difficult it is for a patient to fit his/her colostomy with an appropriate device. 0: perfect adhesion; 10: the device does not adjust to the shape of my skin, and I have permanent leakage.

    Measured: 1 month

  55. Patient difficulty for fitting his/her colostomy with the appropriate sac.

    A visual analog scale is used to determine how difficult it is for a patient to fit his/her colostomy with an appropriate device. 0: perfect adhesion; 10: the device does not adjust to the shape of my skin, and I have permanent leakage.

    Measured: 3 months

  56. Patient difficulty for fitting his/her colostomy with the appropriate sac.

    A visual analog scale is used to determine how difficult it is for a patient to fit his/her colostomy with an appropriate device. 0: perfect adhesion; 10: the device does not adjust to the shape of my skin, and I have permanent leakage.

    Measured: 6 months

  57. Patient difficulty for fitting his/her colostomy with the appropriate sac.

    A visual analog scale is used to determine how difficult it is for a patient to fit his/her colostomy with an appropriate device. 0: perfect adhesion; 10: the device does not adjust to the shape of my skin, and I have permanent leakage.

    Measured: 9 months

  58. Patient difficulty for fitting his/her colostomy with the appropriate sac.

    A visual analog scale is used to determine how difficult it is for a patient to fit his/her colostomy with an appropriate device. 0: perfect adhesion; 10: the device does not adjust to the shape of my skin, and I have permanent leakage.

    Measured: 12 months

  59. Patient difficulty for fitting his/her colostomy with the appropriate sac.

    A visual analog scale is used to determine how difficult it is for a patient to fit his/her colostomy with an appropriate device. 0: perfect adhesion; 10: the device does not adjust to the shape of my skin, and I have permanent leakage.

    Measured: 15 months

  60. Patient difficulty for fitting his/her colostomy with the appropriate sac.

    A visual analog scale is used to determine how difficult it is for a patient to fit his/her colostomy with an appropriate device. 0: perfect adhesion; 10: the device does not adjust to the shape of my skin, and I have permanent leakage.

    Measured: 18 months

  61. Patient difficulty for fitting his/her colostomy with the appropriate sac.

    A visual analog scale is used to determine how difficult it is for a patient to fit his/her colostomy with an appropriate device. 0: perfect adhesion; 10: the device does not adjust to the shape of my skin, and I have permanent leakage.

    Measured: 21 months

  62. Pain medication consumption

    Measured: Day 1

  63. Pain medication consumption

    Measured: 1 month

  64. Pain medication consumption

    Measured: 3 months

  65. Pain medication consumption

    Measured: 6 months

  66. Pain medication consumption

    Measured: 9 months

  67. Pain medication consumption

    Measured: 12 months

  68. Pain medication consumption

    Measured: 15 months

  69. Pain medication consumption

    Measured: 18 months

  70. Pain medication consumption

    Measured: 21 months

  71. Number of colostomy leaks per day

    Measured: Day 1

  72. Number of colostomy leaks per day

    Measured: 1 month

  73. Number of colostomy leaks per day

    Measured: 3 months

  74. Number of colostomy leaks per day

    Measured: 6 months

  75. Number of colostomy leaks per day

    Measured: 9 months

  76. Number of colostomy leaks per day

    Measured: 12 months

  77. Number of colostomy leaks per day

    Measured: 18 months

  78. Number of colostomy leaks per day

    Measured: 15 months

  79. Number of colostomy leaks per day

    Measured: 21 months

  80. Number of colostomy sac changes per day

    Measured: Day 1

  81. Number of colostomy sac changes per day

    Measured: 1 month

  82. Number of colostomy sac changes per day

    Measured: 3 months

  83. Number of colostomy sac changes per day

    Measured: 6 months

  84. Number of colostomy sac changes per day

    Measured: 9 months

  85. Number of colostomy sac changes per day

    Measured: 12 months

  86. Number of colostomy sac changes per day

    Measured: 15 months

  87. Number of colostomy sac changes per day

    Measured: 18 months

  88. Number of colostomy sac changes per day

    Measured: 21 months

  89. Does the patient consider fitting a sac to his/her colostomy to be a difficult task? yes/no

    Measured: Day 1

  90. Does the patient consider fitting a sac to his/her colostomy to be a difficult task? yes/no

    Measured: 1 month

  91. Does the patient consider fitting a sac to his/her colostomy to be a difficult task? yes/no

    Measured: 3 months

  92. Does the patient consider fitting a sac to his/her colostomy to be a difficult task? yes/no

    Measured: 6 months

  93. Does the patient consider fitting a sac to his/her colostomy to be a difficult task? yes/no

    Measured: 9 months

  94. Does the patient consider fitting a sac to his/her colostomy to be a difficult task? yes/no

    Measured: 12 months

  95. Does the patient consider fitting a sac to his/her colostomy to be a difficult task? yes/no

    Measured: 15 months

  96. Does the patient consider fitting a sac to his/her colostomy to be a difficult task? yes/no

    Measured: 18 months

  97. Does the patient consider fitting a sac to his/her colostomy to be a difficult task? yes/no

    Measured: 21 months

  98. Exposition of the prothesis (mesh): yes/no

    Measured: 1 month

  99. Exposition of the prothesis (mesh): yes/no

    Measured: 3 months

  100. Exposition of the prothesis (mesh): yes/no

    Measured: 6 months

  101. Exposition of the prothesis (mesh): yes/no

    Measured: 9 months

  102. Exposition of the prothesis (mesh): yes/no

    Measured: 12 months

  103. Exposition of the prothesis (mesh): yes/no

    Measured: 15 months

  104. Exposition of the prothesis (mesh): yes/no

    Measured: 18 months

  105. Exposition of the prothesis (mesh): yes/no

    Measured: 21 months

  106. Presence/absence of a complication potentially linked to the presence of a mesh?

    Measured: 1 month

  107. Presence/absence of a complication potentially linked to the presence of a mesh?

    Measured: 3 months

  108. Presence/absence of a complication potentially linked to the presence of a mesh?

    Measured: 6 months

  109. Presence/absence of a complication potentially linked to the presence of a mesh?

    Measured: 9 months

  110. Presence/absence of a complication potentially linked to the presence of a mesh?

    Measured: 12 months

  111. Presence/absence of a complication potentially linked to the presence of a mesh?

    Measured: 15 months

  112. Presence/absence of a complication potentially linked to the presence of a mesh?

    Measured: 18 months

  113. Presence/absence of a complication potentially linked to the presence of a mesh?

    Measured: 21 months

  114. Presence/absence of a complication potentially linked to the presence of a mesh?

    Measured: 24 months

  115. Ablation of the mesh: yes/no

    Measured: 1 month

  116. Ablation of the mesh: yes/no

    Measured: 3 months

  117. Ablation of the mesh: yes/no

    Measured: 6 months

  118. Ablation of the mesh: yes/no

    Measured: 9 months

  119. Ablation of the mesh: yes/no

    Measured: 12 months

  120. Ablation of the mesh: yes/no

    Measured: 15 months

  121. Ablation of the mesh: yes/no

    Measured: 18 months

  122. Ablation of the mesh: yes/no

    Measured: 21 months

  123. Ablation of the mesh: yes/no

    Measured: 24 months

  124. Evaluation of colostomy healing by the clinician

    The evaluating clinician (blind to the procedure) will evaluate the healing progress of the colostomy using a visual analog scale.

    Measured: Day 1

  125. Evaluation of colostomy healing by the clinician

    The evaluating clinician (blind to the procedure) will evaluate the healing progress of the colostomy using a visual analog scale.

    Measured: 1 month

  126. Evaluation of colostomy healing by the clinician

    The evaluating clinician (blind to the procedure) will evaluate the healing progress of the colostomy using a visual analog scale.

    Measured: 3 months

  127. Evaluation of colostomy healing by the clinician

    The evaluating clinician (blind to the procedure) will evaluate the healing progress of the colostomy using a visual analog scale.

    Measured: 6 months

  128. Evaluation of colostomy healing by the clinician

    The evaluating clinician (blind to the procedure) will evaluate the healing progress of the colostomy using a visual analog scale.

    Measured: 9 months

  129. Evaluation of colostomy healing by the clinician

    The evaluating clinician (blind to the procedure) will evaluate the healing progress of the colostomy using a visual analog scale.

    Measured: 12 months

  130. Evaluation of colostomy healing by the clinician

    The evaluating clinician (blind to the procedure) will evaluate the healing progress of the colostomy using a visual analog scale.

    Measured: 15 months

  131. Evaluation of colostomy healing by the clinician

    The evaluating clinician (blind to the procedure) will evaluate the healing progress of the colostomy using a visual analog scale.

    Measured: 18 months

  132. Evaluation of colostomy healing by the clinician

    The evaluating clinician (blind to the procedure) will evaluate the healing progress of the colostomy using a visual analog scale.

    Measured: 21 months

  133. Evaluation of colostomy healing by the clinician

    The evaluating clinician (blind to the procedure) will evaluate the healing progress of the colostomy using a visual analog scale.

    Measured: 24 months

  134. Duration of postoperative fever (hours)

    Measured: 10 days

  135. Presence/absence of postoperative fever > 37.2°C

    Measured: Day 1

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Jun 2011 (estimated)
  2. Study startNov 2012
  3. Primary completion31 Dec 2018
  4. Study completion31 Dec 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
200 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01380860
Sponsor's protocol ID
PHRC-N/2011/MP-01
Other IDs
2011-A01572-39
Acronym
GRECCAR 07
Status last verified
Aug 2020
First submitted
22 Jun 2011
Last updated
1 Dec 2025
Results posted
No
Data monitoring committee
Yes

Publications

  • Prudhomme M, Rullier E, Lakkis Z, Cotte E, Panis Y, Meunier B, Rouanet P, Tuech JJ, Jafari M, Portier G, Dubois A, Sielezneff I, Parc Y, Faucheron JL, Meurette G, Lelong B, Piessen G, Karoui M, Fabbro-Peray P, Demattei C, Bertrand MM; GRECCAR research group. End Colostomy With or Without Mesh to Prevent a Parastomal Hernia (GRECCAR 7): A Prospective, Randomized, Double Blinded, Multicentre Trial. Ann Surg. 2021 Dec 1;274(6):928-934. doi: 10.1097/SLA.0000000000004371.

    PubMed 33201089
  • Prudhomme M, Alline M, Chauvat J, Fabbro-Perray P, Ripoche J, Bertrand MM; French Research Group of Rectal Cancer Surgery (GRECCAR). Primary prevention of peristomial hernias via parietal prostheses: A randomized, multicentric study (GRECCAR 7 trial). Dig Liver Dis. 2016 Jul;48(7):812-6. doi: 10.1016/j.dld.2016.03.020. Epub 2016 Apr 5.

    PubMed 27130912

Questions about this trial

What is this clinical trial studying?

A study testing Colostomy with mesh implantation and Simple colostomy in people with Parastomal Hernia, run by Centre Hospitalier Universitaire de Nīmes at 22 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 1 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 22 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Presence/absence of a peristomal hernia (time frame: 24 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01380860, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Dec 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in